Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with SLXP as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.44%||SPDR S&P Pharmaceuticals ETF (XPH)||+11.35 (11.04%)|
|3.02%||Guggenheim S&P MidCap 400 Pure Growth ETF (RFG)||-3.44 (-2.71%)|
|2.74%||First Trust Health Care AlphaDEX Fund (FXH)||+6.11 (10.87%)|
|1.48%||First Trust Mid Cap Growth AlphaDEX Fund (FNY)||+0.72 (2.48%)|
|0.98%||iShares S&P MidCap 400 Growth Index Fund (IJK)||+5.24 (3.31%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
We are a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. Our strategy is to: • identify and acquire rights to products that we believe have potential for near-term regulatory approval or are already approved; • apply our regulatory, product development, and sales and marketing expertise to commercialize these products; and • market our products through our specialty sales and marketing team by primarily focusing on high-prescribing U.S. ... More ...
Where does SLXP fit in the risk graph?
|Annual EPS Est:||$3.25|
|Quarterly EPS Est:||-0.29|